Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, BelgiumToru OkamatsuManager of Business Development at Ajinomoto Bio-Pharma Services
Profile
Toru has worked for Ajinomoto Co., Inc. for 13 years. After gaining experience as Medicinal Chemist, Process Development of AJIPHASE® and CMC affairs, he has been responsible for Business Development and Project Management in Ajinomoto Bio-Pharma Services in Osaka for the past two years. From a CMC perspective, he is currently supporting customers’ oligonucleotide program with his team from pre-clinical to phase Toru holds a M.S. in Kyushu University Graduate School of Science with organic chemistry.
Agenda Sessions
CMC Management for Oligonucleotide Therapeutics: Bridging Research to Clinical
On DemandView SessionCMC Management for Oligonucleotide Therapeutics: Bridging Research to Clinical
09:30View Session